CoChat

Absence of p53-Dependent Apoptosis Combined With Nonhomologous End-Joining Deficiency Leads to a Severe Diabetic Phenotype in Mice

Open access
Tavana, Omid, Puebla-Osorio, Nahum, Sang, Mei, Zhu, Chengming · 2010 · Diabetes

The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: Regulation of pancreatic β-cell mass is essential to preserve sufficient insulin levels for the maintenance of glucose homeostasis. Previously, we reported that DNA double-strand breaks (DSBs) resulting from nonhomologous end-joining (NHEJ) deficiency induce apoptosis and, when combined with p53 deficiency, progressed rapidly into lymphomagenesis in mice. Combination of NHEJ deficiency with a hypomorphic mutation, p53R172P, leads to the abrogation of apoptosis, upregulation of p21, and senescence in precursor lymphocytes. This was sufficient to prevent tumorigenesis. However, these mutant mice succumb to severe diabetes and die at an early age. The aim of this study was to determine the pathogenesis of diabetes in these mutant mice. RESEARCH DESIGN AND METHODS: We analyzed the morphology of the pancreatic islets and the function, proliferation rate, and senescence of β-cells. We also profiled DNA damage and p53 and p21 expression in the pancreas. RESULTS: NHEJ-p53R172P mutant mice succumb to diabetes at 3–5 months of age. These mice show a progressive decrease in pancreatic islet mass that is independent of apoptosis and innate immunity. We observed an accumulation of DNA damage, accompanied with increased levels of p53 and p21, a significant decrease in β-cell proliferation, and cellular senescence in the mutant pancreatic islets. CONCLUSIONS: Combined DSBs with an absence of p53-dependent apoptosis activate p53-dependent senescence, which leads to a diminished β-cell self-replication, massive depletion of the pancreatic islets, and severe diabetes. This is a model that connects impaired DNA repair and accumulative DNA damage, a common phenotype in aging individuals, to the onset of diabetes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/db09-0792

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Figures

FIG. 1. Lig4−/−p53p/p mice succumb to progressive diabetes and reduction of pancreatic islets. A: Blood glucose concentrations from nonfasting animals at indicated ages. Glucose levels were significantly higher in mutant mice starting at 2 months of age. Each data point was an average of at least three animals. B: Blood glucose concentrations measured from a glucose tolerance test in wild-type and Lig4−/−p53p/p mice at 1 and 3 months. Three mice from each genotype were tested. C: Blood insulin concentrations were measured by ELISA. D: Standard insulin tolerance test for insulin sensitivity in 1-month-old wild-type and Lig4−/−p53p/p mice. E: Islet morphometric quantification of Lig4−/−p53p/p and wild-type mice. Multiple sections were analyzed for each pancreas, and three to four mice per group were analyzed; data represent the means ± SEM. F: Representative pancreatic sections from Lig4−/−p53p/p and wild-type mice stained by immunohistochemistry for insulin. *P < 0.0001 versus wild type. Mon, month; Wk, week; WT, wild type. (A high-quality color digital representation of this figure is available in the online issue.)
FIG. 1. Lig4−/−p53p/p mice succumb to progressive diabetes and reduction of pancreatic islets. A: Blood glucose concentrations from nonfasting animals at indicated ages. Glucose levels were significantly higher in mutant mice starting at 2 months of age. Each data point was an average of at least three animals. B: Blood glucose concentrations measured from a glucose tolerance test in wild-type and Lig4−/−p53p/p mice at 1 and 3 months. Three mice from each genotype were tested. C: Blood insulin concentrations were measured by ELISA. D: Standard insulin tolerance test for insulin sensitivity in 1-month-old wild-type and Lig4−/−p53p/p mice. E: Islet morphometric quantification of Lig4−/−p53p/p and wild-type mice. Multiple sections were analyzed for each pancreas, and three to four mice per group were analyzed; data represent the means ± SEM. F: Representative pancreatic sections from Lig4−/−p53p/p and wild-type mice stained by immunohistochemistry for insulin. *P < 0.0001 versus wild type. Mon, month; Wk, week; WT, wild type. (A high-quality color digital representation of this figure is available in the online issue.)CC BY-NC-ND · PubMed Central
FIG. 2. Accumulation of DNA damage and elevated p53 and p21 in Lig4−/−p53p/p mice. A: Pancreatic sections were stained for insulin by immunofluorescence (red), γH2AX foci (green), and DAPI (blue) in 2- and 4-month-old Lig4−/−p53p/p and wild-type mice. γH2AX foci visualized in Lig4−/−p53p/p are more intense in 4- than in 2-month-old mutant mice. No γH2AX foci were visible in wild-type mice. Double immunohistochemical staining of pancreatic sections from 2- or 3-month-old Lig4−/−p53p/p and wild-type mice for (B) p21 and (C) p53 (black) in combination with insulin (red-brown). Magnification ×40. Mon, month; WT, wild type. (A high-quality color digital representation of this figure is available in the online issue.)
FIG. 2. Accumulation of DNA damage and elevated p53 and p21 in Lig4−/−p53p/p mice. A: Pancreatic sections were stained for insulin by immunofluorescence (red), γH2AX foci (green), and DAPI (blue) in 2- and 4-month-old Lig4−/−p53p/p and wild-type mice. γH2AX foci visualized in Lig4−/−p53p/p are more intense in 4- than in 2-month-old mutant mice. No γH2AX foci were visible in wild-type mice. Double immunohistochemical staining of pancreatic sections from 2- or 3-month-old Lig4−/−p53p/p and wild-type mice for (B) p21 and (C) p53 (black) in combination with insulin (red-brown). Magnification ×40. Mon, month; WT, wild type. (A high-quality color digital representation of this figure is available in the online issue.)CC BY-NC-ND · PubMed Central
FIG. 3. Decreased β-cell proliferation and increased cellular senescence in Lig4−/−p53p/p mice. A: Percentage of BrdU incorporation in β-cells of the total β-cells was measured in each age group of Lig4−/−p53p/p mice and plotted in comparison with age-matched wild-type mice. n ≥ 2 mice per time point. Data are the means ± SEM. *P < 0.05 versus wild type. B: Representative islet proliferation of pancreatic sections incubated with anti-BrdU antibody (green) and costained with anti-insulin antibody (red). Arrows indicate BrdU-positive cells. Magnification ×40. C: Immunohistochemical staining for insulin (brown) and β-gal (blue) staining of pancreatic sections from age-matched Lig4−/−p53p/p and wild-type mice. Counterstaining with nuclear fast red. Magnification ×100. Mon, month; Wk, week; WT, wild type. (A high-quality color digital representation of this figure is available in the online issue.)
FIG. 3. Decreased β-cell proliferation and increased cellular senescence in Lig4−/−p53p/p mice. A: Percentage of BrdU incorporation in β-cells of the total β-cells was measured in each age group of Lig4−/−p53p/p mice and plotted in comparison with age-matched wild-type mice. n ≥ 2 mice per time point. Data are the means ± SEM. *P < 0.05 versus wild type. B: Representative islet proliferation of pancreatic sections incubated with anti-BrdU antibody (green) and costained with anti-insulin antibody (red). Arrows indicate BrdU-positive cells. Magnification ×40. C: Immunohistochemical staining for insulin (brown) and β-gal (blue) staining of pancreatic sections from age-matched Lig4−/−p53p/p and wild-type mice. Counterstaining with nuclear fast red. Magnification ×100. Mon, month; Wk, week; WT, wild type. (A high-quality color digital representation of this figure is available in the online issue.)CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 43 references

Cited by

See all 58

Metadata

Authors
Tavana, O., Puebla-Osorio, N., Sang, M., & Zhu, C.
Affiliations
  • The University of Texas MD Anderson Cancer Center (US)
  • Department of Immunology, University of Texas, M.D. Anderson Cancer Center, Houston, Texas;
Corresponding author
Zhu, Chengming
Venue
Diabetes
Published
2009-10-15
Volume
59
Issue
1
Pages
135-142
ISSN
  • 0012-1797 (ISSN-L)
  • 1939-327X
OpenAlex
W2139190473
Cited by
58
References
43
Citations by year
2026: 2 · 2025: 3 · 2024: 5 · 2023: 3 · 2022: 4 · 2021: 7 · 2020: 3 · 2019: 5 · 2018: 3 · 2017: 4 · 2016: 6 · 2015: 2 · 2014: 1 · 2013: 2 · 2012: 1
FWCI
2.37
Type
journal article
Language
en
Open access
Locations
  • Diabetes (publishedVersion, cc-by-nc-nd)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health
  • National Cancer Institute (CA-116933, R01CA116933)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
Keywords
p53, DNA double-strand breaks, beta-cell mass, cellular senescence, p21, DNA damage, pancreatic islets, beta-cell proliferation, DNA repair, aging, lymphomagenesis
MeSH terms
DNA Ligase ATP, Insulin Secretion, Animals, Blood Glucose, Diabetes Mellitus, Experimental, DNA Damage, DNA-Binding Proteins, Immunity, Innate, Immunohistochemistry, Insulin, Islets of Langerhans, Mice, Inbred C57BL, Mice, Inbred Strains, Pancreas, Phenotype, DNA Ligases, Tumor Suppressor Protein p53, Cellular Senescence, Glucose Intolerance, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.